✦ LIBER ✦

P-477 Biweekly carboplatin and gemcitabine for untreated advancednon-small cell lung cancer (NSCLC). A multicenter phase II trial

✍ Scribed by Domine, M.; Garcia gomez, R.; Firvida, J.; Delgado, J.; Estevez, L.; Iglesias Docampo, L.; Leon, A.; Pachon, V.; Casado, V.; Lobo, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter phase II trial with gemcit

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Gemcitabine-cisplatin (GP) vs gemcitabin

✍ P. Mazzanti; C. Massacesi; R. Mattioli; R. Trivisonne; F. Buzzi; G. De Signoribu 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Carboplatin (C) and docetaxel (D) in pre

✍ Jahanzeb, M; Sarna, G; Hirsch, R; Radice, P; Koletsky, A; Martinez, M; Kruglyak, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

29 A phase II trial — Gemcitabine plus c

✍ Rubio, Jaime E.; Sahagún, Guillermo; Rodriguez, Jorge D.; Figueroa, Francisco; M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Paclitaxel and carboplatin in combinatio

✍ Favaretto, A; Paccagnella, A; Tumolo, S; Barbieri, F; Ceresoli, G; Gulisano, M; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 128 KB

A multicenter, phase II study of combina

✍ Edelman, G; Melville, S; Meyer, W; Napier, S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB